Patients and trial design
PsA, ICH, Psoriatic Arthritis
PSORIATIC ARTHRITIS
Adults (≥ 18 years) with a clinical diagnosis of active PsA, who also fulfilled the Classification Criteria for Psoriatic Arthritis (CASPAR), [Both studies were conducted in accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines, applicable regulations governing clinical trial conduct, and the Declaration of Helsinki 1964 and its later amendments. As per Good Clinical Practice (GCP), the trial protocols were approved by an independent ethics committee (IEC)/institutional review board (IRB). All patients provided written informed consent.